NEUBASE THERAPEUTICS INC's ticker is NBSE and the CUSIP is 64132K102. A total of 47 filers reported holding NEUBASE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $689 | -77.0% | 3,723 | +51.5% | 0.00% | – |
Q2 2022 | $3,000 | -85.7% | 2,457 | -67.0% | 0.00% | – |
Q4 2021 | $21,000 | +10.5% | 7,436 | +43.5% | 0.00% | – |
Q3 2021 | $19,000 | +1800.0% | 5,182 | +4406.1% | 0.00% | – |
Q2 2021 | $1,000 | -95.5% | 115 | -96.1% | 0.00% | – |
Q1 2021 | $22,000 | +15.8% | 2,929 | +4.2% | 0.00% | – |
Q4 2020 | $19,000 | +72.7% | 2,812 | +92.7% | 0.00% | – |
Q3 2020 | $11,000 | -77.6% | 1,459 | -74.1% | 0.00% | – |
Q2 2020 | $49,000 | +4800.0% | 5,644 | +3931.4% | 0.00% | – |
Q1 2020 | $1,000 | -50.0% | 140 | -59.5% | 0.00% | – |
Q4 2019 | $2,000 | -89.5% | 346 | -90.8% | 0.00% | – |
Q3 2019 | $19,000 | – | 3,745 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CARNEGIE MELLON UNIVERSITY | 939,412 | $371,000 | 0.21% |
JACOB ASSET MANAGEMENT OF NEW YORK LLC | 470,524 | $186,000 | 0.20% |
CM Management, LLC | 450,000 | $178,000 | 0.20% |
Decheng Capital Management III (Cayman), LLC | 1,000,000 | $395,000 | 0.14% |
AIGH Capital Management LLC | 872,023 | $345,000 | 0.11% |
Greenlight Capital | 2,727,027 | $1,077,000 | 0.08% |
Worth Venture Partners, LLC | 212,035 | $84,000 | 0.05% |
PERKINS CAPITAL MANAGEMENT INC | 98,000 | $39,000 | 0.04% |
Sio Capital Management, LLC | 259,441 | $102,000 | 0.03% |
PRELUDE CAPITAL MANAGEMENT, LLC | 311,000 | $123,000 | 0.00% |